Drugs / CAR19-tTreg
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05114837 | Sep 2024 → Aug 2028 | lymphoid leukemia | Masonic Cancer Center, University of Minnesota | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR19-tTreg | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05114837 ↗ |
| Modality | Cell therapy | “allogeneic CAR19 regulatory T cells (CAR19-tTreg)” NCT05114837 ↗ |